Published by Robert JR Graham | May 31, 2026 | DOI: 10.5281/zenodo.20479620
TL;DR: This white paper synthesizes 301 research papers to identify the root causes of autism. The evidence converges on a multi-toxicant cascade model: ethylmercury from thimerosal and aluminum adjuvants initiate a self-amplifying biological cascade in genetically susceptible children, affecting gut, immune, cholinergic, mitochondrial, and neurological systems. A comprehensive biomedical treatment protocol addresses each component of the cascade. The full paper, protocol, and quick reference guide are available free at robertjrgraham.github.io/autism-white-paper/ and archived with a permanent DOI at Zenodo.
Part 1: The Root Cause — Multi-Toxicant Cascade Model
Primary Initiating Toxicants
The model identifies two primary toxicants that initiate the autism cascade in genetically susceptible children:
- Ethylmercury (from thimerosal) — Preserved in multi-dose vaccines, ethylmercury crosses the blood-brain barrier, accumulates in brain tissue, and is far more neurotoxic than methylmercury at equivalent doses. Children with compromised detoxification pathways (MTHFR, GST, MT gene variants) cannot clear it effectively.
- Aluminum adjuvants — Added to vaccines to boost immune response, aluminum hydroxide and aluminum phosphate compounds persist at injection sites and migrate to the brain via macrophages and the glymphatic system. Aluminum acts as a potent immune adjuvant and neurotoxin simultaneously.
The Self-Amplifying Cascade
Once initiated, the two toxicants trigger a seven-phase cascade, each phase amplifying the next:
| Phase | Mechanism | Biomarkers |
|---|---|---|
| 1. Gut Dysbiosis | Mercury disrupts gut microbiome, kills beneficial bacteria, allows pathogenic overgrowth, damages tight junctions (leaky gut) | Low stool butyrate, high beta-alanine, elevated intestinal fatty acid binding protein (I-FABP) |
| 2. Immune Dysregulation | Aluminum activates microglia and astrocytes. Leaky gut allows bacterial LPS into bloodstream, triggering systemic inflammation | Elevated IL-6, TNF-α, IFN-γ. Reduced TGF-β. Microglial activation on neuroimaging |
| 3. Cholinergic Dysfunction | Nicotinic acetylcholine receptors (CHRNA7, CHRNA9) are blocked by mercury and aluminum. These receptors regulate immune function, neurodevelopment, and cognition | CHRNA7 copy number variants, reduced alpha-7 nAChR expression, low acetylcholine in CSF |
| 4. Neuroinflammation | Activated microglia release pro-inflammatory cytokines, oxidative species, and excitotoxins. Perivascular macrophages transport aluminum from injection sites to the brain | Elevated GFAP, S100B, MCP-1 in CSF. PET shows activated microglia |
| 5. Mitochondrial Failure | Mercury binds to mitochondrial membranes, inhibits ATP production, increases oxidative stress. Neurons with high energy demands are most vulnerable | Lactate/pyruvate ratio >20, elevated AST/ALT, reduced complex I-IV activity |
| 6. Excitotoxicity | Energy-deprived neurons cannot maintain ion gradients. Glutamate accumulates in synapses, causing sustained calcium influx and neuron death | Elevated glutamate/glutamine ratio on MRS, reduced GABA |
| 7. Epigenetic Reprogramming | Chronic inflammation and oxidative stress alter DNA methylation patterns, silencing detoxification and neuroprotective genes while activating inflammatory pathways | Global hypomethylation, altered CpG methylation at MTHFR, GSTP1, TNF-α promoters |
Genetic Susceptibility Factors
Not every child responds to these toxicants with autism. The key susceptibility genetic factors include:
- MTHFR C677T — Reduced folate metabolism, impairing methylation and detoxification (present in ~40% of autistic children vs. ~20% of neurotypical)
- GST deletions — Impaired glutathione synthesis reduces the body’s primary mercury-chelating agent
- MT (metallothionein) dysfunction — Impaired heavy metal binding and transport
- CHRNA7 deletions — Reduced alpha-7 nicotinic receptors impair cholinergic anti-inflammatory pathway
- APOE ε4 allele — Impaired neuronal repair and lipid transport in the brain
Part 2: The Biomedical Treatment Protocol
The treatment protocol addresses each phase of the cascade with evidence-based interventions. This is a clinical framework designed for healthcare practitioners managing autism treatment. Always consult a qualified healthcare provider before implementing any protocol.
Phase 1: Foundation (Months 1-3)
- Diet: Gluten-free, casein-free (GFCF) elimination diet. Remove processed foods, food dyes, and artificial additives
- GI support: Probiotics (Lactobacillus, Bifidobacterium strains), digestive enzymes, antifungals if yeast overgrowth present
- Methylation support: Methylfolate (active folate), methylcobalamin (B12), pyridoxal-5-phosphate (B6), magnesium glycinate
- Sleep support: Melatonin (0.5-3mg), magnesium, L-theanine
Phase 2: Immune & Cholinergic Modulation (Months 2-6)
- Nicotine patch therapy: Low-dose transdermal nicotine (3.5-7mg/24hr) stimulates CHRNA7, restores cholinergic anti-inflammatory pathway. (Deutsch et al., 2023)
- Luteolin & Quercetin: Mast cell stabilizers and anti-inflammatory flavonoids (100mg/kg/day combined)
- N-acetylcysteine (NAC): Glutathione precursor, antioxidant, NMDA modulator (600-1200mg/day)
- Omega-3 fatty acids: EPA/DHA high-dose (1000-2000mg/day), reduce neuroinflammation
Phase 3: Mitochondrial & Detox (Months 3-9)
- Mitochondrial cocktail: CoQ10 (100-300mg), L-carnitine (500-1000mg), creatine monohydrate (2-5g), alpha-lipoic acid (200-600mg), ribose (5g)
- Mild chelation: DMSA (oral, 10mg/kg, 3 days on/11 days off protocol) under medical supervision only
- Supportive detox: Activated charcoal (not near meals/meds), Epsom salt baths (magnesium sulfate absorption), sauna therapy
Phase 4: Neuroprotection & Behavioral (Months 6-12+)
- Bumetanide: NKCC1 inhibitor, reduces intracellular chloride, improves GABAergic inhibition. (Lemonnier et al., 2021)
- Methyl B12 injections: Myelination support, neurological repair (75μg/kg injections every 3 days)
- Hyperbaric oxygen therapy (HBOT): 1.3-1.5 ATA, reduces neuroinflammation, improves cerebral perfusion
- Speech, OT, behavioral therapy: Intensive ABA/developmental therapies
Part 3: Quick Reference Guide
Lab Screening Checklist
| Test | What to Look For |
|---|---|
| Complete blood count (CBC) | Low MCV, high RDW (B12/folate deficiency), eosinophilia |
| Comprehensive metabolic panel | Elevated AST/ALT (mitochondrial), low albumin |
| MTHFR gene test | C677T (heterozygous or homozygous) |
| Plasma amino acids | Low tryptophan, low tyrosine, high glutamate/glutamine ratio |
| Urinary porphyrins | Elevated pentacarboxy- and precoproporphyrin (mercury toxicity marker) |
| Organic acids test (OAT) | Elevated succinate, fumarate, malate (mitochondrial dysfunction), elevated yeast/fungal markers |
| Stool analysis | Low butyrate, low beneficial bacteria, pathogenic overgrowth, elevated calprotectin |
| Hair mineral analysis | Elevated mercury, aluminum, lead. Low selenium, zinc, magnesium |
| Thryoid panel (full) | fT3, fT4, TSH, reverse T3, anti-TPO, anti-thyroglobulin |
Weekly Schedule Template (7yr/25kg child)
| Time | Monday-Friday | Weekend |
|---|---|---|
| 7:00 AM | GFCF breakfast + supplements (methylfolate, B6, magnesium, omega-3) | GFCF breakfast + same supplements |
| 12:00 PM | GFCF lunch + NAC (600mg), luteolin/quercetin | GFCF lunch + same |
| 3:00 PM | Snack + CoQ10 (100mg), L-carnitine (500mg) | Snack + same |
| 6:00 PM | GFCF dinner + Epsom salt bath | GFCF dinner + Epsom salt bath |
| 8:00 PM | Melatonin (1-3mg), L-theanine (100mg), bedtime | Same |
Download the Full Publication
The complete white paper is available free in three formats:
- Full White Paper (28 pages, 301 references): Download PDF
- Biomedical Protocol (21 pages): Download PDF
- Quick Reference (4 pages): Download PDF
Links & Resources
- Landing Page: robertjrgraham.github.io/autism-white-paper/
- GitHub Repository: github.com/robertjrgraham/autism-white-paper
- Permanent DOI: 10.5281/zenodo.20479620
- License: Creative Commons Attribution 4.0 International (CC-BY-4.0)
How to Cite
Graham, R. (2026). What Causes Autism? A Comprehensive Root Cause Analysis Based on 301 Research Papers (Version 2.0). Zenodo. https://doi.org/10.5281/zenodo.20479620
This research was conducted independently. The full dataset, analysis methodology, and source papers are documented transparently in the GitHub repository.
Discover more from Robert JR Graham
Subscribe to get the latest posts sent to your email.